Inhibitory Actions of Potentiating Neuroactive Steroids in the Human α1β3γ2L γ-Aminobutyric Acid Type A Receptor
Molecular Pharmacology · 2024
DOI: 10.1124/molpharm.124.000960 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmacology, 2024. Verfasst von Spencer R Pierce und 5 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Anesthesiology (S.R.P., A.L.G., D.F.C., A.S.E., J.H.S., G.A.), Developmental Biology (D.F.C., A.S.E.), and the Taylor Family Institute…. Hauptthemen laut MEDLINE: Receptors, GABA-A, Xenopus laevis, Neurosteroids. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Departments of Anesthesiology (S.R.P., A.L.G., D.F.C., A.S.E., J.H.S., G.A.), Developmental Biology (D.F.C., A.S.E.), and the Taylor Family Institute for Innovative Psychiatric Research (D.F.C., A.S.E., J.H.S., G.A.), W…
ORCID-Profile: Gustav Akk
Förderung
- NIMH NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Pierce, S. R., Germann, A. L., Covey, D. F., Evers, A. S., Steinbach, J. H., & Akk, G. (2024). Inhibitory Actions of Potentiating Neuroactive Steroids in the Human α1β3γ2L γ-Aminobutyric Acid Type A Receptor. Molecular Pharmacology. https://doi.org/10.1124/molpharm.124.000960
Vancouver
Pierce SR, Germann AL, Covey DF, Evers AS, Steinbach JH, Akk G. Inhibitory Actions of Potentiating Neuroactive Steroids in the Human α1β3γ2L γ-Aminobutyric Acid Type A Receptor. Molecular Pharmacology. 2024. doi:10.1124/molpharm.124.000960
BibTeX
@article{Pierce2024,
author = {Pierce, Spencer R and Germann, Allison L and Covey, Douglas F and Evers, Alex S and Steinbach, Joe Henry and Akk, Gustav},
title = {Inhibitory Actions of Potentiating Neuroactive Steroids in the Human α1β3γ2L γ-Aminobutyric Acid Type A Receptor},
journal = {Molecular Pharmacology},
year = {2024},
doi = {10.1124/molpharm.124.000960}
}
EUVIMED